» Articles » PMID: 38180339

Platelet-to-albumin Ratio is a Potential Biomarker for Predicting Diabetic Nephropathy in Patients with Type 2 Diabetes

Overview
Journal Biomark Med
Date 2024 Jan 5
PMID 38180339
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate whether platelet-to-albumin ratio (PAR) can predict diabetic nephropathy (DN) in type 2 diabetes mellitus (T2DM). A total of 140 patients with T2DM and 40 healthy individuals were enrolled retrospectively. T2DM patients were divided into three groups based on the urinary albumin-to-creatinine ratio, PAR was compared and receiver operating characteristic curve was constructed to evaluate the predictive value of PAR in DN in T2DM. There was a significant increase of PAR in DN among T2DM patients and PAR was positively correlated with serum creatinine, retinol-conjugated protein and β-microglobulin. Moreover, PAR was a risk factor for DN in T2DM patients, which predicted DN in T2DM with high sensitivity and specificity. PAR can be a potential candidate to predict DN in T2DM.

Citing Articles

Nonlinear association between platelet to albumin ratio and disease activity in patients with early rheumatoid arthritis.

Leng L, Shen J, Li L, Li J, Li X, Liu D Sci Rep. 2024; 14(1):27112.

PMID: 39511276 PMC: 11543822. DOI: 10.1038/s41598-024-78582-1.


Platelet-to-albumin ratio: a potential biomarker for predicting all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis.

Ma H, Chen J, Zhan X, Ao S, Deng J, Tang R BMC Nephrol. 2024; 25(1):365.

PMID: 39427118 PMC: 11490134. DOI: 10.1186/s12882-024-03792-8.


Are Platelet-Related Parameters Prognostic Predictors of Renal and Cardiovascular Outcomes in IgA Nephropathy?.

Sagi B, Vas T, Csiky B, Nagy J, Kovacs T J Clin Med. 2024; 13(4).

PMID: 38398303 PMC: 10889748. DOI: 10.3390/jcm13040991.